CNTB
NASDAQ · Biotechnology
Connect Biopharma Holdings L
$2.43
+0.13 (+5.65%)
Open$2.34
Previous Close$2.30
Day High$2.57
Day Low$2.23
52W High$25.73
52W Low$13.35
Volume—
Avg Volume410.4K
Market Cap135.85M
P/E Ratio29.93
EPS$0.60
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+746.1% upside
Current
$2.43
$2.43
Target
$20.56
$20.56
$15.18
$20.56 avg
$23.56
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 69.44M | 70.73M | 65.75M |
| Net Income | 4.31M | 5.04M | 3.90M |
| Profit Margin | 6.2% | 7.1% | 5.9% |
| EBITDA | 5.85M | 6.49M | 5.56M |
| Free Cash Flow | 3.99M | 3.58M | 4.07M |
| Rev Growth | +2.8% | -4.7% | +21.9% |
| Debt/Equity | 0.90 | 0.87 | 0.70 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |